I rate Tronox as a HOLD due to near-term demand weakness in TiO2, margin pressures, and free cash flow concerns despite long-term tailwinds. Recent earnings disappointed, with negative surprises, ...
Chemours Co reports fourth-quarter results Thursday, with investors weighing management’s path to recovery against expectations for another challenging quarter. Analysts expect earnings of 7 cents per ...
Tronox (NYSE:TROX) -0.3% in choppy trading Friday as J.P. Morgan downgraded shares to Neutral from Overweight, saying conditions in the titanium dioxide industry have become more difficult in the near ...
THOOTHUKUDI: Titanium dioxide (TiO2) pigment manufacturers are reeling under an acute shortage of ilmenite, the key raw ...
Tronox (TROX) +4.9% in Monday's trading after the chemical manufacturing company issued preliminary Q4 revenues that beat estimates and said it plans to shut a titanium dioxide plant in China. Tronox ...
The EC's decision to continue TiO2 use in drugs ensures stability and consistent supply, despite safety concerns in food applications. Alternatives to TiO2 exist but face challenges in matching its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results